Trials / Completed
CompletedNCT00319605
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (estimated)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levetiracetam |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2006-07-01
- Completion
- 2006-07-01
- First posted
- 2006-04-27
- Last updated
- 2012-05-25
Locations
54 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00319605. Inclusion in this directory is not an endorsement.